Seres Therapeutics (MCRB) Other Working Capital Changes (2018 - 2021)
Seres Therapeutics (MCRB) posted Other Working Capital Changes of -$5.3 million for Q2 2021, down 13.23% sequentially from -$4.6 million in Q1 2021, and down 1.15% YoY from -$5.3 million in Q2 2020.
Seres Therapeutics (MCRB) Other Working Capital Changes (2018 - 2021) Analysis & Trends
Seres Therapeutics has reported Other Working Capital Changes for 4 years, with the latest figure at -$5.3 million in Q2 2021.
- Quarterly Other Working Capital Changes fell 1.15% year-over-year to -$5.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was -$9.6 million (up 45.63% YoY) and the FY2021 annual result came in at -$4.4 million, up 62.33% from the prior year.
- Other Working Capital Changes slipped to -$5.3 million in Q2 2021 per MCRB's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at -$67000.0 in Q1 2023 and troughed at -$2.5 million in Q1 2026.
- A 5-year average of -$1.4 million and a median of -$1.5 million in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 98.68% in 2020, down 3089.42% in 2020.
- Over 4 years, Other Working Capital Changes stood at $29.8 million in 2018, then sank by 99.37% to $189000.0 in 2019, then soared by 86.24% to $352000.0 in 2020, then plunged by 1595.17% to -$5.3 million in 2021.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$5.3 million, -$4.6 million, and $352000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -5.26 Mn |
| Jun 30, 2021 | -5.26 Mn |
| Jun 30, 2021 | -5.26 Mn |
| Mar 31, 2021 | -4.65 Mn |
| Mar 31, 2021 | -4.65 Mn |
| Mar 31, 2021 | -4.65 Mn |
| Dec 31, 2020 | 352,000.00 |
| Dec 31, 2020 | 352,000.00 |
| Dec 31, 2020 | 352,000.00 |
| Sep 30, 2020 | -80,000.00 |
| Sep 30, 2020 | -80,000.00 |
| Sep 30, 2020 | -80,000.00 |
| Jun 30, 2020 | -5.20 Mn |
| Jun 30, 2020 | -5.20 Mn |
| Jun 30, 2020 | -5.20 Mn |
| Mar 31, 2020 | -6.63 Mn |
| Mar 31, 2020 | -6.63 Mn |
| Mar 31, 2020 | -6.63 Mn |
| Dec 31, 2019 | 189,000.00 |
| Dec 31, 2019 | 189,000.00 |